The behaviour therapeutic falls in management of enuresis, The pharmacological drug of choice for this case is –
**Core Concept**
Enuresis, also known as nocturnal enuresis, is a condition characterized by recurrent involuntary urination during sleep, typically in children. Behaviour therapy, also known as behavioral modification, is a non-pharmacological approach that focuses on altering the underlying causes of enuresis to prevent future episodes. In this context, the therapeutic approach involves establishing a consistent bedtime routine, limiting fluid intake before bedtime, and encouraging the child to wake up during the night to use the bathroom.
**Why the Correct Answer is Right**
The pharmacological drug of choice for managing enuresis is desmopressin, a synthetic analogue of vasopressin. Desmopressin works by reducing the amount of urine produced by the kidneys during the night, thereby reducing the likelihood of nocturnal enuresis. This is achieved through the selective V2 receptor agonism, which decreases the reabsorption of water in the collecting ducts of the kidneys. As a result, the child produces less urine during the night, reducing the risk of enuresis.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify a pharmacological agent, making it an incomplete choice.
**Option B:** This option is incorrect because it is not a commonly used medication for enuresis management.
**Option C:** This option is incorrect because it is not a suitable pharmacological agent for treating enuresis due to its side effect profile and mechanism of action.
**Clinical Pearl / High-Yield Fact**
Desmopressin is a popular choice for managing nocturnal enuresis due to its efficacy and safety profile. However, it is essential to note that desmopressin should not be used as a long-term solution and should be accompanied by behavioral modifications to address the underlying causes of enuresis.
**Correct Answer:** D. Desmopressin